CARMAT Announces Filing Today for Insolvency and Requesting Being Placed in Receivership

Suspension of CARMAT shares trading starting June 30, 2025, before stock market opening

PARIS, June 30, 2025–(BUSINESS WIRE)–Regulatory News:

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT“), today announces filing for insolvency¹ and requesting to be placed in receivership² to the Versailles Economic Affairs Court³, as well as the suspension of CARMAT shares trading, starting June 30, 2025, before stock market opening.

Insolvency filing and request to be placed in receivership

On June 20, 2025, CARMAT announced in a…